Latest News

U.S. Immigration Fund announces another EB-5 Project Loan Repayment - 855 Avenue of the Americas

NEW YORK, Dec. 13, 2022 /PRNewswire/ -- U.S. Immigration Fund (USIF), a USCIS approved EB-5 Regional Center, is pleased to announce that USIF's 855 Avenue of the America's$80 million loan has been fully repaid by the borrower. 855 Avenue of the Americas is a mixed-use 41-story, residential-focuse...

2022-12-13 00:08 5577

Aires Investment Holdings Granted U.S. Patent for Encryption Method Involving Artificial Intelligence

The encryption method developed potentially improves the security of millions of devices SINGAPORE, Dec. 12, 2022 /PRNewswire/ -- Aires Investment Holdings  (the "Company" or "Aires"), a groundbreaking technology company based inSingapore, announced today that the United States Patent and Tradem...

2022-12-12 23:36 3870

Think tanks call for innovation in responsible sourcing of minerals and metals across Africa, Western and Central Asia

Future Minerals Forum (FMF) partners, the Development Partner Institute (DPI) and Clareo, are jointly issuing a cogent new paper focused on the importance of responsibly sourcing minerals. They call for a multi-stakeholder, multi-sector approach, and stress the roleSaudi Arabia and the wider regi...

2022-12-12 23:34 4031

"Internet in China" Public Service Advertising Series of the China Internet Development Foundation: A Symphony of Life

BEIJING, Dec. 12, 2022 /PRNewswire/ -- China Internet Development Foundation and ANT Group have jointly launched  "Internet inChina" public service advertising series on the topic of mobile payment called "A Symphony of Life", where it looked back at the changes and promotion of innovation of mob...

2022-12-12 23:31 3355

Ascletis Announces Positive Phase I Clinical Results of Oral RdRp Inhibitor ASC10 for COVID-19

--The exposure of active drug ASC10-A after twice daily dosing 800 mg double prodrug ASC10 in Chinese subjects was 94% of that after twice daily dosing 800 mg single prodrug molnupiravir in Japanese subjects --Based on Ascletis' Phase I results of ASC10 and molnupiravir's clinical efficacy data ...

2022-12-12 23:29 5617

Global Chip Industry Projected to Invest More Than $500 Billion in New Factories by 2024, SEMI Reports

MILPITAS, Calif., Dec. 12, 2022 /PRNewswire/ -- The worldwide semiconductor industry is projected to invest more than$500 billion in 84 volume chipmaking facilities starting construction from 2021 to 2023, with segments including automotive and high-performance computing fueling the spending incr...

2022-12-12 23:00 2833

The 39th Harbin International Ice and Snow Festival is around the corner

HARBIN, China, Dec. 12, 2022 /PRNewswire/ -- Located in the heartland of Northeast Asia, Harbin enjoys superior natural conditions, a special urban history and unique ice and snow culture. It is an international metropolis where different cultures meet and interact. People here live in harmony an...

2022-12-12 22:12 3191

e& Enterprise invests into Bespin Global

* e& Enterprise, a leading digital transformation services provider based in Abu Dhabi, signed a definitive agreement to invest over $100 million to Bespin Global. * As a part of the investment structure, e& Enterprise and Bespin Global will form a joint venture to provide cloud managed and p...

2022-12-12 22:00 4219

Frost & Sullivan Recognizes VitalConnect with the 2022 New Product Innovation Award for Its Leading-edge Wearable Patient Monitoring Device

VitalConnect delivers a cost-effective, 24/7 remote patient monitoring platform that outperforms existing patient monitoring devices on the market. SAN ANTONIO, Texas, Dec. 12, 2022 /PRNewswire/ -- Based on its recent analysis of the wearable biosensor industry,Frost & Sullivan recognizes VitalC...

2022-12-12 22:00 3012

TD Holdings, Inc. Awarded Top 100 China Industrial Internet Enterprise of 2022

SHENZHEN, China, Dec. 12, 2022 /PRNewswire/ -- TD Holdings, Inc. (Nasdaq: GLG) (the "Company"), a commodities trading service provider in China, today announced that its online to offline e-commerce commodities trading platform, tongdow.com, was awarded Top 100 China Industrial Internet Enterpris...

2022-12-12 22:00 4285

Pop Culture Group's Joint Venture to Receive Growth Investment from Nest Investment Management Co., Ltd.

XIAMEN, China, Dec. 12, 2022 /PRNewswire/ -- Pop Culture Group Co., Ltd ("Pop Culture" or the "Company") (Nasdaq: CPOP), a hip-hop culture company headquartered inChina, today announced that the Company's joint venture, Shenzhen Jam Box Technology Co., Ltd ("JBT"), entered into an equity investme...

2022-12-12 22:00 4142

Sapia.ai to invest in bringing the best kept secret in HR tech to America

From Australia, with love NEW YORK, Dec. 12, 2022 /PRNewswire/ -- Following its phenomenal success in transforming hiring for some ofAustralia's biggest retail brands, Sapia.ai is excited to grow its share of the US market in 2023 with the appointment of Russell Mikowski as President, Americas. ...

2022-12-12 22:00 2941

SOLIF Announces Launch of Forest-Green Collection Bags

NEW YORK, Dec. 12, 2022 /PRNewswire/ -- SOLIF, a sustainable urban fashion brand is pleased to announce the launch of their first bag collection, Forest-Green, live on the site today. The collection is including backpacks, totes, and shoulder bags. The primary material of the collection is astoni...

2022-12-12 22:00 2693

CARsgen Presents Data from China Pivotal Phase II Trial of BCMA CAR T Zevor-cel (CT053) at 2022 ASH Annual Meeting

SHANGHAI, Dec. 12, 2022 /PRNewswire/ -- CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on innovative CAR T-cell therapies for the treatment of hematologic malignancies and solid tumors, announces thatat the 2022 American Society of Hematology (the "ASH") Annual Mee...

2022-12-12 21:50 3258

Yum China Achieves Highest Score in its Industry for the Third Consecutive Year on the Dow Jones Sustainability Index

Green power purchase program launched with two pilot restaurants SHANGHAI, Dec. 12, 2022 /PRNewswire/ -- Yum China Holdings, Inc. (the "Company" or "Yum China", NYSE: YUMC and HKEX: 9987) today announced that the Company was ranked the best in the 88 companies assessed in the Restaurant & Leisur...

2022-12-12 21:41 3988

Tantech Participated in Setting International Standards for Bamboo-based Activated Carbon

LISHUI, China, Dec. 12, 2022 /PRNewswire/ -- Tantech Holdings Ltd (NASDAQ: TANH) ("Tantech" or the "Company") today announced that its subsidiary, Zhejiang Tantech Bamboo Charcoal Co., Ltd., had received a certificate from the Bamboo and Rattan Technical Committee of the International Organizatio...

2022-12-12 21:30 3317

"Picturesque Zhejiang" Promotion Season in Europe and Asia launched in Hangzhou

HANGZHOU, China, Dec. 12, 2022 /PRNewswire/ -- The launching ceremony of the "Picturesque Zhejiang" Promotion Season inEurope and Asia was held on Friday in Hangzhou. Hosted by Zhejiang Provincial Department of Culture and Tourism, the event welcomed distinguished guests, including Mr.Xu Peng, De...

2022-12-12 21:05 2336

KPS CAPITAL PARTNERS ANNOUNCES PROMOTION

RAHUL SEVANI ELEVATED TO PARTNER NEW YORK, Dec. 12, 2022 /PRNewswire/ -- KPS Capital Partners, LP ("KPS") announced today that Rahul Sevani has been promoted to Partner. KPS Co-Founders and Managing Partners Michael Psaros and David Shapiro, together with Managing Partner Raquel Vargas Palmer, s...

2022-12-12 21:00 4791

PharmAbcine Announces Collaboration Agreement with MSD to Evaluate Anti-VISTA Antibody PMC-309 in Combination with KEYTRUDA® (pembrolizumab)

DAEJEON, South Korea, Dec. 12, 2022 /PRNewswire/ -- PharmAbcine Inc. (KOSDAQ: 208340ks), a clinical-stage biotech company focusing on the development of next-generation antibody therapeutics, announced today that the Company has entered into a clinical collaboration agreement with MSD (Merck & Co...

2022-12-12 21:00 3140

Asieris'Bladder Cancer Diagnostic Drug Hexvix® Completed Dosing of First Patient in Real-World Clinical Study

SHANGHAI, Dec. 12, 2022 /PRNewswire/ -- Asieris Pharmaceuticals (688176), a global biopharma company specializing in discovering, developing and commercializing innovative drugs for the treatment of genitourinary tumors and other related diseases, announced that Hexvix®, a drug used for bladder c...

2022-12-12 20:59 2451